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SUMMARY
A total of 73 isolates (57 Enterobacter cloacae and 16 Enterobacter agglomerans), recovered during an outbreak of bacteremia
in the Campinas area, São Paulo, Brazil, were studied. Of these isolates, 61 were from parenteral nutrition solutions, 9 from blood
cultures, 2 from a sealed bottle of parenteral nutrition solution, and one was of unknown origin. Of the 57 E. cloacae isolates, 54 were
biotype 26, two were biotype 66 and one was non-typable. Of 39 E. cloacae isolates submitted to ribotyping, 87.2% showed the same
banding pattern after cleavage with EcoRI and BamHI. No important differences were observed in the antimicrobial susceptibility
patterns among E. cloacae isolates exhibiting the same biotype, serotype and ribotype. All E. agglomerans isolates, irrespective of
their origin, showed same patterns when cleaved with EcoRI and BamHI. The results of this investigation suggest an intrinsic
contamination of parenteral nutrition solutions and incriminate these products as a vehicle of infection in this outbreak.
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INTRODUCTION
Enterobacter species are emerging as important human pathogens,
particularly among hospitalized patients5,14,33,37. Among 13 species
currently recognized as members of the genus Enterobacter11,12, E.
cloacae and E. aerogenes are the most frequently isolated species
associated with human diseases1,10,17,19,30. E. agglomerans, commonly
found in plants, soil, water and food stuffs, although rarely recognized
as an agent of endogenous nosocomial infections6,8,14, can cause epidemics
among hospitalized patients when associated with the use of contaminated
intravenous products due to its ability to grow in commercial infusion
fluids22,23.
Single source outbreaks of Enterobacter infections have been
frequently traced to contaminated intravenous products, blood products,
distilled water and pressure monitoring devices2,7,22,24,25,31,32,34,35. A long-
lasting epidemic caused by Enterobacter spp involving many hospitals
and associated with the use of intrinsically contaminated intravenous
solutions was reported in the 1970’s in the United States by MAKI et al.22.
In March 24, 1997, one hospital of Campinas County, São Paulo
State, Brazil, notified the Municipal Secretary of Health of an outbreak
of bacteremia associated with intravenous therapy. According to the
epidemiological investigation28 , this outbreak began between 21 and 22
March, and was associated with the use of a parenteral nutrition solution
produced by one manufacturer and bearing the same batch number.
Enterobacter cloacae and Enterobacter agglomerans were isolated from
in-use infusion bags available in two of eight affected hospitals of
Campinas County. Among 49 affected patients of this Municipality, 12
died (two adults and 10 newborns). Bacteremia was the typical clinical
manifestation seen in the majority of patients receiving infusion bags
after delivered by the manufacturer.
The purpose of this study was to investigate, by phenotypical and
genotypic methods, the relatedness of E. cloacae and E. agglomerans
strains recovered during this outbreak.
MATERIAL AND METHODS
Bacterial strains. A total of 73 isolates, 57 of them Enterobacter
cloacae, and 16 Enterobacter agglomerans, were studied. Of the 57 E.
cloacae isolates, 7 were from blood cultures, 48 from solutions
administered to patients, one was from a sealed bottle and one was of
unknown origin. Concerning the 16 E. agglomerans isolates, 2 were
isolated from blood cultures, 13 from solutions administered to patients
and one was from a sealed bottle. These isolates were recovered at
Instituto Adolfo Lutz, Regional Laboratory, Campinas, in the Department
of Clinical Microbiology of Campinas University, UNICAMP, and in
the Laboratory of the Hospital “Maternidade de Campinas“, Campinas,
São Paulo, Brazil. All isolates were recovered in March 1997 during an
outbreak of bacteremia that occurred in hospitals using parenteral
nutrition solutions produced by one manufacturer.
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Table 1
Origin and phenotypic and genotypic characteristics of  enterobacteria isolated during the outbreak associated with the use of
parenteral nutrition solution, March, 1997.
Patient Source Microorganism Biotype Serotype Ribotype Antimicrobial Resistance Pattern
1 PNS1 E. cloacae 26 O3 E1B1 CX CF AP GN
E. cloacae 66 NT2 E3B3 CX CF AP
2 PNS E. cloacae NT NT E5B5 CX CF AP
3 PNS E. cloacae 26 O3 E1B1 CX CF GN
4 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
E. cloacae 26 R E1B1 CX CF GN
E. agglomerans -3 - E6B6 S
Blood E. cloacae 26 O3 E1B1 CX CF AP GN
E. agglomerans - - E6B6 S4
5 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
E. cloacae 26 R5 E1B1 CX CF GN
E. cloacae 26 O3 - CX CF AP GN
E. agglomerans - - E6B6 S
6 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
E. cloacae 26 R E1B1 CX CF AP GN
E. cloacae 26 O3 - CX CF AP GN
E. agglomerans - - E6B6 S
Blood E. cloacae 26 03 E1B1 CX CF AP GN
7 PNS E. cloacae 26 O3 E1B1 CX CL AP GN
E. cloacae 66 NT E4B4 Multiresistant6
E. cloacae 26 O3 - CX CF AP GN
E. agglomerans - - E6B6 Multiresistant7
8 PNS E. cloacae 26 O19 E2B2 Multiresistant 8
9 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
E. cloacae 26 R - CX CF AP GN
E. cloacae 26 R - CX CF AP GN
E. agglomerans - - E6B6 S
Blood E. cloacae 26 O3 E1B1 CX CF AP GN
10 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
E. cloacae 26 O3 - CX CF AP GN
E. cloacae 26 R - CX CF AP GN
11 Blood E. cloacae 26 R E1B1 CX CF AP GN
12 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
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Patient Source Microorganism Biotype Serotype Ribotype Antimicrobial Resistance Pattern
13 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
E. cloacae 26 O3 - CX CF AP GN
E. agglomerans - - E6B6 S
? E. cloacae 26 O3 E1B1 CX CF
14 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
E. cloacae 26 R - CX CF AP GN
E. agglomerans - - E6B6 S
15 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
E. cloacae 26 O3 - CX CF AP GN
E. cloacae 26 R - CX CF AP GN
16 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
E. cloacae 26 O3 - CX CF AP GN
17 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
18 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
E. agglomerans - - E6B6 S
Blood E. agglomerans - - E6B6 S
19 Blood E. cloacae 26 O3 E1B1 CX CF AP GN
20 PNS E. cloacae 26 R E1B1 CX CF AP GN
E. cloacae 26 R - CX CF AP GN
E. agglomerans - - E6B6 S
21 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
E. cloacae 26 O3 - CX CF AP GN
E. cloacae 26 O3 - CX CF AP GN
E. cloacae 26 R - CX CF AP GN
E. agglomerans - - E6B6 S
E. agglomerans - - E6B6 AP GN TT
E. agglomerans - - - S
22 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
23 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
24 PNS E. cloacae 26 O14 NT CX CF AP
25 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
E. cloacae 26 O3 - CX CF AP GN
E. cloacae 26 R - CX CF AP GN
E. agglomerans - - E6B6 AP GN TT
26 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
27 PNS E. cloacae 26 O3 E1B1 CX CF AP GN
28 Blood E. cloacae 26 O3 E1B1 CX CF AP GN
29 Blood E. cloacae 26 O3 E1B1 CX CF AP GN
Sealed Bottle E. cloacae 26 O3 E1B1 CX CF AP GN
E. agglomerans - - E6B6 S
PNS1 (parenteral nutrition  solution); NT2 (non-typable); -3 (not tested); S4 (susceptible to all tested drugs); R5 (rough strain); multiresistant6
(resistant to CX,CF, AP, AM, TT,CLO, SUT, CPZ, CRX); multiresistant7 (resistant  to AP, TT,AM,GN,CLO); multiresistant8 (resistant to
CX,CF,AP,TT,AM,SUT,CPZ,GN,CTX); ? (unknown origin)
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Biochemical identification. All isolates were subjected to
biochemical identification9, and all E. cloacae were biotyped as
previously described27,36.
Serotyping. Nineteen E. cloacae isolates were serotyped in the
Central Public Health Laboratory, Laboratory of Hospital Infection,
Colindale, London, UK. The remaining 38 E. cloacae were serotyped at
Instituto Adolfo Lutz, Central Public Health Laboratory, using O-antisera
prepared with standard E. cloacae strains received from the Laboratory
of Hospital Infection, London, UK. O-serotyping was performed
according to methods previously described15.
Antibiotic susceptibility testing. The susceptibility of all isolates
to antimicrobial agents was determined by the standard disk diffusion
method26 using the following commercial disks (Cecon, Centro de
Controle e Produtos para Diagnósticos, S. Paulo, Brazil): amikacin (AM,
30µg), cefoperozone (CPZ, 75µg), cefotaxime (CTX, 30µg), imipenen
(IPM, 10µg), ciprofloxacin (CIP, 5µg), tetracyclin (TT, 30µg),
chloramphenicol (CLO, 30µg), sulfamethoxazole-trimethoprim (SUT,
1.25/23.75µg), ampicillin (AP, 10µg), cephalotin (CF, 30µg), gentamicin
(GN, 10µg), and cephalexin (CX, 30µg).
Ribotyping. All isolates recovered from blood cultures were
ribotyped as well as the isolates from sealed bottle. Among isolates from
in-use parenteral nutrition solutions we selected at least one isolate of
each bottle. Chromosomal DNA of E. cloacae and E. agglomerans was
extracted and purified as previously described3. DNA samples (3 µg)
were cleaved with the restriction enzymes EcoRI and BamHI according
to the reaction conditions recommended by the manufacturer (Pharmacia,
LKB). DNA fragments were subjected to horizontal electrophoresis in
0.8% agarose (Sigma) in 0.04 M TRIS-acetate and 0.001 M EDTA buffer,
and restriction fragments were transferred under vacuum (Vacugene,
Pharmacia, LKB) to nylon membranes . The membranes were hybridized
with the 16+23S cDNA probe transcribed by reverse transcriptase from
E. coli rRNA (Boerhinger Mannheim, Germany) and labelled with
digoxigenin according to POPOVIC et al.29. A Haemophilus aegyptius
(strain # 3031) EcoRI DNA digest (fragment sizes of 1492 ,1713, 3228,
3789, 4960, 5575, 6334, and 17613 bp) was used as molecular marker.
Fragment sizes were estimated with a computer program (DNASTAR
Computer System for Molecular Biology and Genetics, London, UK).
RESULTS
Biotyping and serotyping. Of E. cloacae isolates 39 were assigned
to biotype 26 / serotype O3, 13 to biotype 26 / OR ( rough ), four belonged
to other biotypes / serotypes and one was non-typable by biotyping or
serotyping. The characteristics of all strains are summarized in Table 1.
Antimicrobial susceptibility patterns. The majority of E. cloacae
showed no important differences in the antimicrobial susceptibility
patterns, being homogeneously resistant to ampicillin, cephalothin,
cephalexin, and gentamicin. One isolate of biotype 26 / O19 and one of
biotype 66 / NT were resistant to 9 drugs. Of 16 E. agglomerans isolates,
13 were susceptible to all tested drugs, 2 were resistant to ampicillin,
gentamicin and tetracycline and one was resistant to ampicillin,
gentamicin, tetracycline, amikacin and chloramphenicol.
Ribotyping. DNA samples of 39 E. cloacae and 15 E. agglomerans
were digested with EcoRI and BamHI. All 34 E. cloacae isolates
belonging to biotype 26 and to serotype O3 or OR (rough isolates),
irrespective of their origin (solution administered to patients, sealed bottle
of parenteral nutrition solution and blood cultures) were homogeneously
cleaved with Eco RI, generating 16 fragments ranging in size from 1.3
to 22.9 kp, and were assigned to pattern E1. These 34 isolates, which
also showed a unique pattern (B1) with 8 bands ranging in size from 6.0
to 25.8 kp when cleaved with BamHI, were assigned to ribotype E1B1.
DNA sample (extraction was repeated twice) of one E. cloacae isolate
(biotype 26 / serotype O14) was sheared and was not digested. E. cloacae
isolates belonging to biotype 26 / serotype O19 (one isolate), biotype 66
/ NT (two isolates) and NT / NT (one isolate) displayed patterns distinct
from E1B1 when cleaved with EcoRI or BamHI and were classified as
ribotypes E2B2, E3B3, E4B4, and E5B5, respectively. All E.
agglomerans isolates when cleaved with EcoRI showed a unique pattern
(E6) with 12 fragments ranging from 1.7 to 14.5 kp. The homogeneity
of these isolates was confirmed with the second enzyme BamHI. All E.
agglomerans isolates were classified as ribotype E6B6. Figure 1 shows
the banding patterns of E. cloacae and E. agglomerans recovered from
solutions administered to patients, from blood cultures and from one
sealed bottle of parenteral nutrition solution, after digestion with EcoRI
and BamHI, respectively. Schematic representation of the banding
patterns of ribotypes of E. cloacae and E. agglomerans is shown in
Figure 2.










Fig. 1 - Banding patterns of E. cloacae belonging to biotype 26/serotype O3 (lanes 2 to 6)
generated by EcoRI (pattern E1), and of E. agglomerans (lanes 8 to 12) after cleavage with
BamHI (pattern B6). Isolates were obtained from blood cultures (lanes 2, 3, 8, and 9), solutions
administered to patients (lanes 4, 5 10 and 11) and sealed bottle (lanes 6 and 12). Lane 1 and
7, size marker (H. aegyptius 3031 EcoRI DNA digest, fragment size in kilobases).
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Fig. 2 - Schematic representation of the banding patterns E1 to E5 of E. cloacae obtained from DNA after digestion with EcoRI (lanes 2 to 6), and banding patterns B1 to B5 after digestion with
BamHI (lanes 9 to 13). Banding patterns of E. agglomerans from DNA after digestion with EcoRI (E6) and BamHI (B6) are represented in Lane 7 and 14. Lane 1 and 8, DNA molecular weight
marker.
DISCUSSION
Phenotypic methods when used in combination could be sufficiently
discriminatory and satisfactory to differentiate the majority of clinical
isolates of E. cloacae13,36. Using conventional typing methods, we could
differentiate a main group of 39 E. cloacae represented by isolates
characterized as biotype 26 / serotype O3. E. cloacae serotype O3 strains
are the most frequently isolated serotype from human infections16,36 and
are probably widely disseminated in the environment.
This group of phenotypically similar isolates was genetically
homogeneous as determined by ribotyping. On the other hand, four
isolates which belonged to distinct biotypes and serotypes were also
heterogeneous when assayed by ribotyping.
Biochemical and genotypic similarities shared by E. cloacae isolated
from a sealed bottle of parenteral nutrition solution and E. cloacae isolated
from solutions administered to patients point to the intrinsic
contamination of these solutions, probably from environmental origin
because of the antimicrobial susceptibilty pattern. Extrinsic
contamination of the solutions administered to patients is unlikely,
considering that nocomial strains of E. cloacae are usually multiresistant.
Multiple resistant E. cloacae strains belonging to some biotypes such
as biotype 26 and 66 are frequently associated with human infections
probably because these strains are present in some hospital units such as
intensive care units37. It was not surprising that such nosocomial
pathogens could be isolated from some infusion bottles as was seen
with Patient 7, where in addition to the intrinsic contamination, an
extrinsic contamination by multiple resistant nosocomial E. cloacae
(biotype 66 / NT and ribotype E4B4) problably occurred. An extrinsic
contamination was also suspected in an infusion bottle administered to
Patient 8 from which it was isolated a multiple resistant E. cloacae strain
belonging to biotype 26 / serotype O19, and ribotype E2B2.
The high genetic heterogeneity of E. agglomerans4,20,21 makes it
difficult to establish a satisfactory system for its identification. According
to FARMER11, only cultures that are yellow pigmented and triple
decarboxylase-negative strains are usually identified as E. agglomerans.
All of our isolates that were triple decarboxylase-negative, although none
was yellow pigmented, were identified as E. agglomerans. The lack of
phenotypic methods to discriminate strains and to support similarities
among strains of E. agglomerans is a drawback in epidemiological
studies. In this study the relatedness of E. agglomerans strains isolated
from solutions administered to patients, from blood cultures and from a
sealed bottle of parenteral nutrition solution could be only confirmed by
ribotyping. Both EcoRI and BamHI provided a precise evidence of strains
relatedness.
Ribotyping proved to be an extremely useful method to confirm the
identity of our isolates as other investigators had already reported13,18,35,38.
In our sample, most of E. cloacae isolates were assigned to the same
ribotype (E1B1) which assesses the genetic similarity of the isolates of
the main group identified as biotype 26/serotype O3 or 26/OR of distinct
origins.
Our results suggest that E. cloacae and E. agglomerans were present
in the solutions when they were delivered to the hospitals (intrinsic
contamination) since at least one of the two microorganisms present in a
sealed bottle was isolated from the solutions administered to 26 patients.
On the other hand, recovery of the same microorganisms from blood
cultures of patients using these solutions incriminates them as a vehicle
of transmission of these agents during the outbreak.
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RESUMO
Epidemiologia molecular de um surto de bacteriemia por
Enterobacter cloacae e Enterobacter agglomerans ocorrido na
região de Campinas, S. Paulo, Brasil
Foram estudadas um total de 73 cepas (57 de E. cloacae e 16
E. agglomerans), isoladas durante um surto de bacteriemia ocorrido na
região de Campinas, S. Paulo. Entre estas cepas, 61 foram isoladas de
solução de nutrição parenteral, 9 de sangue, 2 de bolsa fechada de solução
de nutrição parenteral e uma era de origem desconhecida. Entre as 57
cepas de E. cloacae, a maioria das cepas foram do biotipo 26/sorotipo
O3 (39 cepas) e do biotipo 26/OR (13). Entre as 39 cepas de E. cloacae
ribotipadas, 87,2% apresentaram o mesmo padrão de bandas com EcoRI
e BamHI. Cepas de E. cloacae pertencentes ao mesmo biotipo, sorotipo
e ribotipo não apresentaram diferenças significativas em relação ao padrão
de sensibilidade aos agentes antimicrobianos. Todas as cepas de E.
agglomerans, independente da origem, pertenciam ao mesmo ribotipo
após a clivagem com EcoRI e BamHI. Os resultados obtidos sugerem
uma contaminação intrínseca das soluções de nutrição parenteral,
incriminando-as como o veículo de transmissão dos agentes etiológicos
do surto.
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SUMMARY OF THESIS*
CAVALHEIRO, Norma de Paula – Análise dos sorotipos do VHC identificados em pacientes da cidade de São Paulo, através de método imunoenzimático.
São Paulo, 1999.  (Dissertação de Mestrado - Faculdade de Medicina da Universidade de São Paulo).
ANALYSIS OF SEROTYPES OF HCV IN PATIENTS FROM THE CITY OF SÃO PAULO, BY MEANS OF A
ENZYME-IMMUNOASSAY METHOD
With the objective of analyzing  the prevalence of the different types
of Hepatitis C Virus (HCV) in a population of chronic carriers of HCV,
through a serologic method (MUREX HCV Serotyping Assay), 219
patients were studied who showed a positive polymerase chain reaction.
This sera were submitted to immunoenzymatic tests for the detection of
antibodies in relation to HCV types 1,2,3,4,5 and 6. The samples were
diluted and incubated in the presence of heterologous competing
peptides, with microwells coated with serotype-specific antigens of HCV.
Of the 219 patients, it was possible to detect the HCV serotype in 166,
revealing  a sensitivity of 75.8%. The results showed a predominance of
type 1 (70.0%) in our medium, followed by type 3 (22.3%) and type 2
(4.2%). Serotypes 4 and 5 were present in 1.8% of the patients, but
always associated with serotype 1. These samples, in spite of fulfilling
the prerequisites of validity for testing, showed a very high optical density
reading for all types of viruses tested, including positive and negative
controls. The possibility of  cross reactions in these cases should be
considered. Confirmation by genotyping and a more detailed investigation
on the origin and mode of acquisition of the HCV of these patients should
be researched. Type 6 was not confirmed in any of the samples tested
and probably was not present in this particular collection. The
epidemiological parameters evaluated were: age, sex and means of
transmission. Of the 166 patients diagnosed with the HCV, 108 (65.1%)
were men and 58 (34.9%) were women. The age of the patients varied
from 12 to 73 years, the average being  41.1 years. The means of
transmission mentioned were blood transfusion in 52 (31.3%) cases,
intravenous drug use in 18 (10.8%) cases, by tattoos in 8 (4.8%) cases,
6 (3.6%) cases were sexually transmitted, 3 (1.8%) were by accident
with a needle, 2 (1.2%) through work in the health field, one (0.6%)
through acupuncture and one by being hemophiliac. Sixty one (36.7%)
patients were not able to offer any risk factor which justified the
acquisition of the HCV infection. No significant difference was verified
among the different types of HCV found and the different epidemiological
parameters studied. The predominance of types 1, 3 and 2 is compatible
with other genotyping studies which involved Brazilian samples,
particularly in the city of São Paulo. The samples which showed high or
low dense optical reading for all the wells of the same samples tested
even the positive or negative controls, suggested confirmation by
sequencing or genotyping. The practicality obtained by the HCV
serotyping test, in spite of the fact that it does not identify  the sub type,
can be useful in clinical practice and helpful in the prognostication of
the disease, not needing the technology demanded by the tests which
involve molecular biology.
